Connect with us

Biotech

Moonz Increases Revenues by 42% in 2021 and finalizes its Market Entry in Catalonia

The company maintains its growth forecasts. By 2022, Moonz expects to earn just over eight million euros, which would double the figure for the year of the outbreak of the pandemic, and by 2023 it expects to reach thirteen million euros in sales. Moonz was taken over by Vitaldent in 2020 with the aim of boosting its expansion nationally and internationally.

Published

on

Moonz’s revenues soar. The children’s orthodontic brand, whose majority shareholder is the Vitaldent group, closed the 2021 financial year with a turnover of $6.09 million (€5.7 million), a figure 42.5% higher than that recorded in 2020, when the company earned $4.28 million (€4 million), Javier Girón de Velasco, CEO and co-founder of Moonz, said. In addition, the group is preparing to enter the Catalan market.

The company currently has ten clinics located in Madrid (La Moraleja, La Zarzuela, Padre Damián, Boadilla, Arturo Soria, Tres Cantos and Rivas), Bilbao, Málaga and London. In the United Kingdom, Moonz has had a center in Fulham since 2012.

In just one year, Moonz has opened five clinics, and the company’s objective, as Girón acknowledged last September, is to have thirty facilities by 2024, which will require an investment of approximately $5.35 million (€5 million). One of the next openings will take place this summer in the Barcelona town of Sant Cugat del Vallès, Catalonia being a new destination for Moonz. The company is investing around one million euros in sponsorship and marketing activities.

Read more about Moonz and find the latest business headlines with our companion app Born2Invest.

Moonz currently has ten fully operational clinics

The company maintains its growth forecasts. By 2022, Moonz expects to earn just over eight million euros, which would double the figure for the year of the outbreak of the pandemic, and by 2023 it expects to reach thirteen million euros in sales.

The company has been operating for more than a decade and has already treated more than 40,000 patients. It is a family project that was founded in 2011 by Myriam Sada, president of Moonz, Javier Girón de Velasco and the financier Jaime Girón.

SEE ALSO  7 health-boosting superfoods to start eating right now

Moonz was taken over by Vitaldent in 2020 with the aim of boosting its expansion nationally and internationally. “Our strategy is and has to be that of an oil slick,” said the CEO and co-founder of this group of dental clinics for children.

Javier Girón de Velasco, CEO of Moonz Girón de Velasco is a dentist and an expert in orthodontics from the Complutense University and the San Rafael Hospital in Madrid, where he obtained the highest European qualification in orthodontics.

After more than eleven years of professional experience, Girón de Velasco participated in the construction of Moonz. He brought together a group of more than thirty people. He is also president of the next edition of the Congress of the Spanish Society of Orthodontics to be held from 22 to 25 June 2022 in Madrid, the main themes of which will be children’s orthodontics and aesthetics in orthodontics.

__

(Featured image by MEISTERvideo via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Olivia McCall is passionate about education, women and children’s rights, and the environment. A long-time investor, she covers news about the latest stocks (lately marijuana and tech), IPOs and indices, and is always on the lookout for socially responsible startups. She also writes about the food sector, and has a keen interest on cryptocurrencies.

Continue Reading